Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 3
1994 1
1995 1
1996 1
1997 4
1998 1
2000 1
2002 1
2003 3
2004 2
2005 1
2006 2
2012 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD. Doronina SO, et al. Among authors: francisco ja. Nat Biotechnol. 2003 Jul;21(7):778-84. doi: 10.1038/nbt832. Epub 2003 Jun 1. Nat Biotechnol. 2003. PMID: 12778055
Xenopus-FV3 host-pathogen interactions and immune evasion.
Jacques R, Edholm ES, Jazz S, Odalys TL, Francisco JA. Jacques R, et al. Among authors: francisco ja. Virology. 2017 Nov;511:309-319. doi: 10.1016/j.virol.2017.06.005. Epub 2017 Jun 16. Virology. 2017. PMID: 28625407 Free PMC article.
Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
Law CL, Cerveny CG, Gordon KA, Klussman K, Mixan BJ, Chace DF, Meyer DL, Doronina SO, Siegall CB, Francisco JA, Senter PD, Wahl AF. Law CL, et al. Among authors: francisco ja. Clin Cancer Res. 2004 Dec 1;10(23):7842-51. doi: 10.1158/1078-0432.CCR-04-1028. Clin Cancer Res. 2004. PMID: 15585616 Free article.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page